Vascular

Bibi I. Hasnain, MD
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO

Arshag D. Mooradian, MD
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO

Address: Arshag D. Mooradian, MD, Division of Endocrinology, Saint Louis University, 1402 South Grand Boulevard, St. Louis, MO 63104; e-mail [email protected]

Bibi I. Hasnain, MD
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO

Arshag D. Mooradian, MD
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO

Address: Arshag D. Mooradian, MD, Division of Endocrinology, Saint Louis University, 1402 South Grand Boulevard, St. Louis, MO 63104; e-mail [email protected]

Bibi I. Hasnain, MD
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO

Arshag D. Mooradian, MD
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO

Address: Arshag D. Mooradian, MD, Division of Endocrinology, Saint Louis University, 1402 South Grand Boulevard, St. Louis, MO 63104; e-mail [email protected]

William S. Harris, PhD
Lipid and Diabetes Research Center, Mid America Heart Institute of Saint Luke’s Hospital and Department of Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO

Address: William S. Harris, PhD, 4320 Wornall Road, Suite 128, Kansas City, MO 64111; e-mail [email protected]

The author has indicated that he is a major stock shareholder and cofounder of OmegaMetrix, a company involved in measuring blood levels of omega-3 fatty acids.

William S. Harris, PhD
Lipid and Diabetes Research Center, Mid America Heart Institute of Saint Luke’s Hospital and Department of Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO

Address: William S. Harris, PhD, 4320 Wornall Road, Suite 128, Kansas City, MO 64111; e-mail [email protected]

The author has indicated that he is a major stock shareholder and cofounder of OmegaMetrix, a company involved in measuring blood levels of omega-3 fatty acids.

William S. Harris, PhD
Lipid and Diabetes Research Center, Mid America Heart Institute of Saint Luke’s Hospital and Department of Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO

Address: William S. Harris, PhD, 4320 Wornall Road, Suite 128, Kansas City, MO 64111; e-mail [email protected]

The author has indicated that he is a major stock shareholder and cofounder of OmegaMetrix, a company involved in measuring blood levels of omega-3 fatty acids.

Stephen H. Sinclair, MD
Department of Ophthalmology, Crozer Chester Medical Center, Hahnemann University, Philadelphia, PA

Cherie Delvecchio, BS
Pennsylvania College of Optometry, Elkins Park

Address: Stephen H. Sinclair, MD, Crozer Chester Medical Center, Upland, PA 19013; e-mail [email protected]

Dr. Sinclair has indicated that he is a stock shareholder in Philadelphia Ophthalmic Imaging systems.

Stephen H. Sinclair, MD
Department of Ophthalmology, Crozer Chester Medical Center, Hahnemann University, Philadelphia, PA

Cherie Delvecchio, BS
Pennsylvania College of Optometry, Elkins Park

Address: Stephen H. Sinclair, MD, Crozer Chester Medical Center, Upland, PA 19013; e-mail [email protected]

Dr. Sinclair has indicated that he is a stock shareholder in Philadelphia Ophthalmic Imaging systems.

Stephen H. Sinclair, MD
Department of Ophthalmology, Crozer Chester Medical Center, Hahnemann University, Philadelphia, PA

Cherie Delvecchio, BS
Pennsylvania College of Optometry, Elkins Park

Address: Stephen H. Sinclair, MD, Crozer Chester Medical Center, Upland, PA 19013; e-mail [email protected]

Dr. Sinclair has indicated that he is a stock shareholder in Philadelphia Ophthalmic Imaging systems.

Mark W. Russo, MD
Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY

Ira M. Jacobson, MD
Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY

Address: Mark W. Russo, MD, University of North Carolina, Division of Digestive Diseases, CB#7080, Bioinformatics Building, Room 1104, Mason Farm Road, Chapel Hill, NC 27599-7080; e-mail [email protected]

Mark W. Russo, MD
Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY

Ira M. Jacobson, MD
Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY

Address: Mark W. Russo, MD, University of North Carolina, Division of Digestive Diseases, CB#7080, Bioinformatics Building, Room 1104, Mason Farm Road, Chapel Hill, NC 27599-7080; e-mail [email protected]

Mark W. Russo, MD
Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY

Ira M. Jacobson, MD
Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY

Address: Mark W. Russo, MD, University of North Carolina, Division of Digestive Diseases, CB#7080, Bioinformatics Building, Room 1104, Mason Farm Road, Chapel Hill, NC 27599-7080; e-mail [email protected]

Michael T. Modic, MD
Chairman, Division of Radiology, The Cleveland Clinic Foundation

Nancy Obuchowski, PhD
Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation

Address: Michael T. Modic, MD, Chairman, Division of Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Michael T. Modic, MD
Chairman, Division of Radiology, The Cleveland Clinic Foundation

Nancy Obuchowski, PhD
Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation

Address: Michael T. Modic, MD, Chairman, Division of Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Michael T. Modic, MD
Chairman, Division of Radiology, The Cleveland Clinic Foundation

Nancy Obuchowski, PhD
Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation

Address: Michael T. Modic, MD, Chairman, Division of Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Keith Ellis, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin Brener, MD
Director, Angiography Core Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Sorin Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Keith Ellis, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin Brener, MD
Director, Angiography Core Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Sorin Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Keith Ellis, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin Brener, MD
Director, Angiography Core Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Sorin Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Roy K. Greenberg, MD
Director, Endovascular Research, Department of Vascular Surgery, The Cleveland Clinic

Address: Roy K. Greenberg, MD, Director, Endovascular Research, Department of Vascular Surgery, S40, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Boston Scientific, Cook, Cordis Endovascular, Jomed, and Vascutek corporations and serves as a consultant for the Boston Scientific and Cook corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Roy K. Greenberg, MD
Director, Endovascular Research, Department of Vascular Surgery, The Cleveland Clinic

Address: Roy K. Greenberg, MD, Director, Endovascular Research, Department of Vascular Surgery, S40, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Boston Scientific, Cook, Cordis Endovascular, Jomed, and Vascutek corporations and serves as a consultant for the Boston Scientific and Cook corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Roy K. Greenberg, MD
Director, Endovascular Research, Department of Vascular Surgery, The Cleveland Clinic

Address: Roy K. Greenberg, MD, Director, Endovascular Research, Department of Vascular Surgery, S40, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Boston Scientific, Cook, Cordis Endovascular, Jomed, and Vascutek corporations and serves as a consultant for the Boston Scientific and Cook corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Darius M. Moshfeghi, MD
Cole Eye Institute, The Cleveland Clinic

Hilel Lewis, MD
Professor and Chairman, Division of Ophthalmology; Director, Cole Eye Institute, The Cleveland Clinic

Address: Hilel Lewis, MD, Cole Eye Institute, The Cleveland Clinic Foundation, I30, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Darius M. Moshfeghi, MD
Cole Eye Institute, The Cleveland Clinic

Hilel Lewis, MD
Professor and Chairman, Division of Ophthalmology; Director, Cole Eye Institute, The Cleveland Clinic

Address: Hilel Lewis, MD, Cole Eye Institute, The Cleveland Clinic Foundation, I30, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Darius M. Moshfeghi, MD
Cole Eye Institute, The Cleveland Clinic

Hilel Lewis, MD
Professor and Chairman, Division of Ophthalmology; Director, Cole Eye Institute, The Cleveland Clinic

Address: Hilel Lewis, MD, Cole Eye Institute, The Cleveland Clinic Foundation, I30, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]